Immunome, Inc (IMNM) announced today that its discovery engine has isolated potent antibodies capable of neutralizing several SARS-CoV-2 (the virus that causes COVID-19) variants, including the South African Variant (B.1.351), in pseudovirus testing.
This effort is part of the company’s . . .
This content is for paid subscribers.
Trick or Trade February 18, 2021